Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.
about
Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysisPromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelPrognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.Preoperative pulmonary function correlates with systemic inflammatory response and prognosis in patients with non-small cell lung cancer: results of a single-institution retrospective study.Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis.Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patientsPerioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell CarcinomaPrognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIsPrognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysisPretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung CancerPrognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysisPrognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapyPretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric AdenocarcinomaInfluence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer.Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapyThe Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.Neutrophil-to-lymphocyte ratio is effective prognostic indicator for post-amputation patients with critical limb ischemia.Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.Th17 cells in cancer: the ultimate identity crisis.Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysisPrognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer.Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.Platelet-to-Lymphocyte Ratio and Use of NSAIDs During the Perioperative Period as Prognostic Indicators in Patients With NSCLC Undergoing Surgery.Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment.Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection.Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
P2860
Q26801799-F7C48F34-DFAA-4654-B0C4-FC93457AF0A1Q28384920-8F67605D-92D0-41D4-89DA-3B0DEBFDA247Q33602512-917D905C-F854-44B7-B397-527B6C9F6B5CQ33689106-748FB32E-2E72-4BC3-916F-4367126D2751Q35581934-0C6C2B65-2109-4F83-858D-8526C5F6770EQ35660696-BD045E83-EB55-4800-B498-F959670813EEQ35663441-1D8344C1-854E-45A3-95A0-8177A40F4861Q35755373-2D0CCFF0-294D-4155-9A1E-DD48DD3C9736Q35781911-B6FBAD23-E154-41CD-B379-65843B697E00Q35817001-EBDEFEF4-769B-485C-BDA2-5849619547AEQ35884531-B54805EE-0048-4EA5-9F18-12C4CDA91AF2Q35897794-FD9DD7E8-5930-47DA-816B-E8323483DF8CQ35936092-37B3A6C7-5FCC-4CC3-B9F1-3DF23AEE8E54Q35996748-E6EA8BA6-A181-470E-863C-F916B9F3B698Q36151154-10085907-047B-4D96-88BD-103521BFD98EQ36650991-31B843AB-3231-4858-AC70-B9D457DAE26FQ36824972-07CF9B7B-D46A-42F9-8445-FBD775D1B3DEQ36999075-D0575A38-9A79-4432-97A3-031BD4932CA3Q37286453-1646CB4D-F1FE-46D2-99FA-D2DCA4C04B5EQ37295840-267E87EB-8220-4542-B504-EF7C23A28DAFQ37310842-A4FAB854-A97D-4D1B-92A0-2F8F130A51B5Q37376757-0193EA86-1618-4CCA-ACB0-2FD087B2CBA1Q37465628-C54A4A0C-7B91-4F21-B41A-9EE616A47BE6Q37611903-780EF9DB-D6ED-485C-99EB-EF8A4C019BAAQ37626610-8B9A30FF-8996-4653-97EB-73AC1DEF0869Q38225542-B39704F1-2761-40F2-AF79-B2267E20FCC6Q38622803-7E2D7D85-AC0F-4F09-B570-7374E2EA9D42Q38650153-4CB80321-F6DE-46BE-A649-F99C057464A7Q38661489-9AECA777-EA4A-455F-A0AA-3D204C778323Q38774380-E39E9AFF-C19E-4DEE-BAEA-E62BE15A087DQ38982694-C8629D01-0534-4808-BAC4-851BDBCF11A9Q39181674-42153C99-E93F-45AB-9118-0478EAD18229Q39458282-9CB711E7-7BF6-47FF-A95F-5C8E1E6DD3F7Q39479184-200781DC-4CE4-444D-B48C-1E8530DA7B18Q39647693-BA7318B2-CD71-4776-AE80-B9C5F4DB530BQ39653822-42A2436B-91FB-49A6-95EB-6EDFF643D765Q40006646-30369BF4-C3DE-4946-A226-F9D33B5CF54AQ40268169-D5D7DECC-31BF-4586-9F9D-5937C406D0C4Q40401380-66E4013D-8C05-43E3-A530-5006DC0AD026Q40547023-513E465E-6FE3-4A77-8FB5-9DAF90428ED8
P2860
Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic performance of infl ...... le non-small cell lung cancer.
@en
Prognostic performance of infl ...... le non-small cell lung cancer.
@nl
type
label
Prognostic performance of infl ...... le non-small cell lung cancer.
@en
Prognostic performance of infl ...... le non-small cell lung cancer.
@nl
prefLabel
Prognostic performance of infl ...... le non-small cell lung cancer.
@en
Prognostic performance of infl ...... le non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
Prognostic performance of infl ...... le non-small cell lung cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.145
P407
P577
2014-03-25T00:00:00Z